129 related articles for article (PubMed ID: 35938683)
1. Development and validation of a liquid chromatography coupled with tandem mass spectrometry method for determining total and unbound pamiparib in human plasma and brain tumors.
Jiang J; Bao X; Yue Y; Schiff D; Bindra R; Li J
Biomed Chromatogr; 2022 Dec; 36(12):e5478. PubMed ID: 35938683
[TBL] [Abstract][Full Text] [Related]
2. Determination of total and unbound ribociclib in human plasma and brain tumor tissues using liquid chromatography coupled with tandem mass spectrometry.
Bao X; Wu J; Sanai N; Li J
J Pharm Biomed Anal; 2019 Mar; 166():197-204. PubMed ID: 30660034
[TBL] [Abstract][Full Text] [Related]
3. A liquid chromatography with tandem mass spectrometry method for quantitating total and unbound ceritinib in patient plasma and brain tumor.
Bao X; Wu J; Sanai N; Li J
J Pharm Anal; 2018 Feb; 8(1):20-26. PubMed ID: 29568664
[TBL] [Abstract][Full Text] [Related]
4. An aqueous normal-phase chromatography coupled with tandem mass spectrometry method for determining unbound brain-to-plasma concentration ratio of AZD1775, a Wee1 kinase inhibitor, in patients with glioblastoma.
Wu J; Sanai N; Bao X; LoRusso P; Li J
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Aug; 1028():25-32. PubMed ID: 27318641
[TBL] [Abstract][Full Text] [Related]
5. A validated LC-MS/MS method for determination of neuro-pharmacokinetic behavior of niraparib in brain tumor patients.
Knight W; Margaryan T; Sanai N; Tovmasyan A
J Pharm Biomed Anal; 2024 Aug; 245():116150. PubMed ID: 38657366
[TBL] [Abstract][Full Text] [Related]
6. Development and Validation of High-Throughput Bioanalytical Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Method for the Quantification of Newly Synthesized Antitumor Carbonic Anhydrase Inhibitors in Human Plasma.
Abdel-Megied AM; Eldehna WM; Abdelrahman MA; Elbarbry FA
Molecules; 2020 Dec; 25(23):. PubMed ID: 33291270
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of LC-MS/MS methods for the quantification of 101BHG-D01, a novel, long-acting and selective muscarinic receptor antagonist, and its main metabolite M6 in human plasma, urine and feces: Application to a clinical study in healthy Chinese subjects.
Gao H; Cheng M; Liu H; Ding L
J Pharm Biomed Anal; 2023 Sep; 233():115498. PubMed ID: 37285657
[TBL] [Abstract][Full Text] [Related]
8. High-performance liquid chromatography-mass spectroscopy/mass spectroscopy method for simultaneous quantification of total or free fraction of mycophenolic acid and its glucuronide metabolites.
Figurski MJ; Korecka M; Fields L; Waligórska T; Shaw LM
Ther Drug Monit; 2009 Dec; 31(6):717-26. PubMed ID: 19809389
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a sensitive liquid chromatography tandem mass spectrometry assay for the simultaneous determination of ten kinase inhibitors in human serum and plasma.
Aghai F; Zimmermann S; Kurlbaum M; Jung P; Pelzer T; Klinker H; Isberner N; Scherf-Clavel O
Anal Bioanal Chem; 2021 Jan; 413(2):599-612. PubMed ID: 33155133
[TBL] [Abstract][Full Text] [Related]
10. Determination of the sulfate and glucuronide conjugates of levornidazole in human plasma and urine, and levornidazole and its five metabolites in human feces by high performance liquid chromatography-tandem mass spectrometry.
He G; Guo B; Zhang J; Li Y; Wu X; Fan Y; Chen Y; Cao G; Yu J
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Apr; 1081-1082():87-100. PubMed ID: 29518721
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous determination of 11 alkaloids in rat plasma by LC-ESI-MS/MS and a pharmacokinetic study after oral administration of total alkaloids extracted from Naucleaofficinalis.
Wang G; Wang H; Lin Z; Hou L; Wang JY; Sun L
J Ethnopharmacol; 2022 Jan; 282():114560. PubMed ID: 34454053
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous determination of ABT-888, a poly (ADP-ribose) polymerase inhibitor, and its metabolite in human plasma by liquid chromatography/tandem mass spectrometry.
Wiegand R; Wu J; Sha X; LoRusso P; Li J
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Feb; 878(3-4):333-9. PubMed ID: 20005184
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a sensitive LC-MS/MS method for the assay of four PARP inhibitors in human plasma and its application in ovarian cancer patients.
Wei Y; Liang H; Liu S; Guan S; Ma K; Guan Y; Chen Y; Huang M; Wang X; Lan C
J Pharm Biomed Anal; 2024 Jan; 237():115758. PubMed ID: 37832476
[TBL] [Abstract][Full Text] [Related]
14. Validation and implementation of a liquid chromatography/tandem mass spectrometry assay for quantitation of the total and unbound RO4929097, a γ-secretase inhibitor targeting Notch signaling, in human plasma.
Wu J; Wiegand R; LoRusso P; Li J
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jun; 879(19):1537-43. PubMed ID: 21497565
[TBL] [Abstract][Full Text] [Related]
15. Method development and validation for simultaneous determination of six tyrosine kinase inhibitors and two active metabolites in human plasma/serum using UPLC-MS/MS for therapeutic drug monitoring.
Zhang M; Liu X; Chen Z; Jiang S; Wang L; Tao M; Miao L
J Pharm Biomed Anal; 2022 Mar; 211():114562. PubMed ID: 35124453
[TBL] [Abstract][Full Text] [Related]
16. Validation and implementation of a liquid chromatography/tandem mass spectrometry assay to quantitate aminoflavone (NSC 686288) in human plasma.
Wiegand R; Wu J; Sha X; LoRusso P; Heath E; Li J
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 May; 877(14-15):1460-4. PubMed ID: 19349217
[TBL] [Abstract][Full Text] [Related]
17. A quantitative method for the simultaneous detection of SR9009 and SR9011 in equine plasma using liquid chromatography-electrospray ionization-tandem mass spectrometry.
Kwak YB; Yu J; Yoo HH
Drug Test Anal; 2022 Aug; 14(8):1532-1538. PubMed ID: 35396832
[TBL] [Abstract][Full Text] [Related]
18. Sensitive liquid chromatography/tandem mass spectrometry method for the determination of the lipophilic antipsychotic drug chlorpromazine in rat plasma and brain tissue.
Zhang G; Terry AV; Bartlett MG
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jul; 854(1-2):68-76. PubMed ID: 17452027
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of an LC-MS/MS method for the determination of a novel thienoquinolin urea transporter inhibitor PU-48 in rat plasma and its application to a pharmacokinetic study.
Zhang ZY; Wang X; Liu D; Zhang H; Zhang Q; Lu YY; Li P; Lou YQ; Yang BX; Lu C; Lou YX; Zhang GL
Biomed Chromatogr; 2018 Apr; 32(4):. PubMed ID: 29193233
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a bioanalytical method for the simultaneous determination of heroin, its main metabolites, naloxone and naltrexone by LC-MS/MS in human plasma samples: Application to a clinical trial of oral administration of a heroin/naloxone formulation.
Moreno-Vicente R; Fernández-Nieva Z; Navarro A; Gascón-Crespí I; Farré-Albaladejo M; Igartua M; Hernández RM; Pedraz JL
J Pharm Biomed Anal; 2015 Oct; 114():105-12. PubMed ID: 26037158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]